Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 194 of 194 entries
Sorted by: Best Match Show Resources per page
PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results.

Journal of vascular surgery

Clair DG, Mustapha JA, Shishehbor MH, Schneider PA, Henao S, Bernardo NN, Deaton DH.
PMID: 34019990
J Vasc Surg. 2021 Nov;74(5):1626-1635. doi: 10.1016/j.jvs.2021.04.057. Epub 2021 May 18.

OBJECTIVE: We report the 6- and 12-month outcomes of the PROMISE I early feasibility study after treatment of no-option chronic limb-threatening ischemia (CLTI) with percutaneous deep vein arterialization (pDVA) using the LimFlow System.METHODS: Thirty-two patients with no-option CLTI, previously...

Cite
Clair DG, Mustapha JA, Shishehbor MH, et al. PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. J Vasc Surg. 2021;74(5):1626-1635doi: 10.1016/j.jvs.2021.04.057.
Clair, D. G., Mustapha, J. A., Shishehbor, M. H., Schneider, P. A., Henao, S., Bernardo, N. N., & Deaton, D. H. (2021). PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. Journal of vascular surgery, 74(5), 1626-1635. https://doi.org/10.1016/j.jvs.2021.04.057
Clair, Daniel G, et al. "PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results." Journal of vascular surgery vol. 74,5 (2021): 1626-1635. doi: https://doi.org/10.1016/j.jvs.2021.04.057
Clair DG, Mustapha JA, Shishehbor MH, Schneider PA, Henao S, Bernardo NN, Deaton DH. PROMISE I: Early feasibility study of the LimFlow System for percutaneous deep vein arterialization in no-option chronic limb-threatening ischemia: 12-month results. J Vasc Surg. 2021 Nov;74(5):1626-1635. doi: 10.1016/j.jvs.2021.04.057. Epub 2021 May 18. PMID: 34019990.
Copy Download .nbib Format: NLM
Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry.

The Prostate

Zenner ML, Helou YB, Deaton RJ, Sverdlov M, Wang H, Kajdacsy-Balla A, Macias V, Voisine C, Murray M, Abdulkadir SA, Murphy AB, Nonn L.
PMID: 34855273
Prostate. 2021 Dec 02; doi: 10.1002/pros.24273. Epub 2021 Dec 02.

BACKGROUND: The metabolism of normal prostate relies on glycolysis, with prostate cancer having reduced glycolysis and increased aerobic metabolism. Advanced glycation end products (AGEs) accumulate in tissues as a result of age and glycolytic rate. Differential AGE levels were...

Cite
Zenner ML, Helou YB, Deaton RJ, et al. Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry. Prostate. 2021;doi: 10.1002/pros.24273.
Zenner, M. L., Helou, Y. B., Deaton, R. J., Sverdlov, M., Wang, H., Kajdacsy-Balla, A., Macias, V., Voisine, C., Murray, M., Abdulkadir, S. A., Murphy, A. B., & Nonn, L. (2021). Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry. The Prostate, . https://doi.org/10.1002/pros.24273
Zenner, Morgan L, et al. "Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry." The Prostate vol. (2021). doi: https://doi.org/10.1002/pros.24273
Zenner ML, Helou YB, Deaton RJ, Sverdlov M, Wang H, Kajdacsy-Balla A, Macias V, Voisine C, Murray M, Abdulkadir SA, Murphy AB, Nonn L. Advanced glycation end-products (AGEs) are lower in prostate tumor tissue and inversely related to proportion of West African ancestry. Prostate. 2021 Dec 02; doi: 10.1002/pros.24273. Epub 2021 Dec 02. PMID: 34855273.
Copy Download .nbib Format: NLM
Showing 193 to 194 of 194 entries